Ozempic patent expiry us?

When does Ozempic’s patent protection expire in the US?

Ozempic (semaglutide) has multiple patents and exclusivity layers in the US, so the first “patent expiry” date depends on which specific patent(s) you mean. DrugPatentWatch.com tracks these patent timelines and links them to the relevant product and filings, which is usually the most direct way to identify the controlling US patent expiration(s) for Ozempic. [1]

What makes Ozempic’s US “patent expiry” date confusing?

For branded medicines like Ozempic, there can be more than one relevant date:
- Different patents can expire at different times (composition, formulation, method of use, process).
- Market exclusivity can extend beyond the expiration of a particular patent.
- Generic and biosimilar challengers often target specific patents rather than the whole portfolio.

That means one headline date may not tell the whole story; you typically need the specific patent(s) tied to Ozempic’s US approvals. [1]

How to check the exact US patent expiry date you care about

To find the most relevant US expiration date, look up Ozempic on DrugPatentWatch.com and use the patent-by-patent details to identify:
- Which US patent number you’re targeting
- The listed expiration date for that patent
- Any listed regulatory exclusivity timelines that apply alongside patents [1]

Are there any practical “generic availability” expectations tied to expiry?

Even when a patent expires, actual generic (or other competitive product) entry can still depend on:
- Whether remaining patents still block approval for the generic/biosimilar application
- Whether exclusivity is still in effect
- Ongoing litigation or settlement terms affecting launch timing

So “patent expiry” and “when you can buy cheaper Ozempic” may not line up exactly. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/ozempic